Accès ouvert
2026
article
OpenAlex
Allison Drosdowsky, Karen Elaine Lamb, Luc te Marvelde, Peter Gibbs et autres
Introduction Timeliness in colorectal cancer diagnosis and treatment is crucial, however recommendations are often not evidence based. This study aimed to assess associations between the length of diagnostic and treatment interval and overall survival and stage of disease in colorectal cancer using …
au
(code pays fourni par la source)
Accès ouvert
2026
preprint
OpenAlex
Grace Y Kim, Eugene Wang, Saskia Freytag, Sarah A. Best et autres
BACKGROUND Quality dashboards are increasingly being used in oncology to support monitoring and standardisation of quality of care against defined benchmarks, yet there is limited consensus or guidelines on effective dashboard design. OBJECTIVE This scoping review aims to summarise the evidence supporting …
Accès ouvert
2025
article
OpenAlex
CATHERINE M. DUNN, Grace Y Kim, Peter Gibbs, Lucy Gately
Background: Glioblastoma (GBM) is the most aggressive primary brain neoplasm in adults, characterized by high recurrence and poor post-recurrence survival. Validated quality indicators (QIs) have been used to assess the quality of care in many cancer populations, now providing clinicians, researchers, and …
au
(code pays fourni par la source)
Accès ouvert
2025
article
OpenAlex
Allison Drosdowsky, Karen Elaine Lamb, Luc te Marvelde, Peter Gibbs et autres
This research aimed to assess the length of intervals before diagnosis and treatment for colorectal cancer in Australia using linked datasets, and to determine any factors associated with interval length. A colorectal cancer clinical registry was linked to general practice electronic medical …
au
(code pays fourni par la source)
2025
article
OpenAlex
Jane McKenzie, CATHERINE M. DUNN, Grace Gard, Brian Huong Canh Le et autres
Previous reports indicated many patients with advanced cancer and limited life expectancy have ongoing preventive medication prescription (PMP) of uncertain benefit and increased risk. Our review of palliative care oncology admissions found high rates of PMP (69%) at time of first palliative …
au
(code pays fourni par la source)
2025
article
OpenAlex
CATHERINE M. DUNN, Jeanne Tie, Peter Gibbs
This Viewpoint describes the optimal approach to therapy selection for patients with cancer using biomarkers.
au
(code pays fourni par la source)
2024
article
OpenAlex
CATHERINE M. DUNN, Jeremy Shapiro, Margaret S. Lee, Rachel Wong et autres
au
(code pays fourni par la source)
Accès ouvert
2024
article
OpenAlex
Matthew Loft, Vanessa S. Wong, Suzanne Kosmider, Rachel Wong et autres
BACKGROUND: Immunotherapy has emerged as a standard treatment for deficient mismatch repair (dMMR) metastatic colorectal cancer (mCRC). Pembrolizumab became widely available as a first-line (1L) option in Australia following the Pharmaceutical Benefits Scheme (PBS) listing in August 2021. The uptake of new …
au
(code pays fourni par la source)
2024
article
OpenAlex
Grace Y Kim, Azim Jalali, Grace Gard, Justin M Yeung et autres
au
(code pays fourni par la source)
Accès ouvert
2024
article
OpenAlex
CATHERINE M. DUNN, Michael T. Halpern, Daniel Sapkaroski, Peter Gibbs
BACKGROUND: Quality indicators are essential for measuring and benchmarking the quality of cancer care. Although there are well-established metrics for early-stage colorectal cancer (CRC), few exist for advanced CRC. This scoping review aimed to collate and review all quality indicators for metastatic …
au, us
(code pays fourni par la source)
Accès ouvert
2024
article
OpenAlex
Helen Pham, Sangeetha Ramanujam, Hui‐Ling Yeoh, Phillip N. Antippa et autres
Introduction The assessment and management of oligometastatic colorectal cancer has evolved over the last two decades. We aimed to examine trends in the presentation, management and outcomes of patients presenting with liver-only disease, given recent changed standards for baseline imaging, and evolving …
au, cn
(code pays fourni par la source)
Accès ouvert
2024
article
OpenAlex
Jack A. Reed, CATHERINE M. DUNN
No description available
gb
(code pays fourni par la source)